financetom
Business
financetom
/
Business
/
Dentsply Sirona's Q2 Adjusted EPS, Revenue Decline; Lowers 2024 Guidance; Shares Drop 4% Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dentsply Sirona's Q2 Adjusted EPS, Revenue Decline; Lowers 2024 Guidance; Shares Drop 4% Pre-Bell
Jul 31, 2024 6:48 AM

09:26 AM EDT, 07/31/2024 (MT Newswires) -- Dentsply Sirona ( XRAY ) reported Q2 adjusted earnings Wednesday of $0.49 per diluted share, compared with $0.51 a year earlier.

Analysts surveyed by Capital IQ expected $0.49.

Revenue for the quarter ended June 30 was $984 million, compared with $1.03 billion a year earlier.

Analysts surveyed by Capital IQ expected $993.4 million.

The dental equipment company lowered its adjusted earnings and revenue guidance for full-year 2024. It now expects adjusted adjusted earnings of $1.96 to $2.02 per share, down from previous guidance of $2.00 to $2.10. And it now expects organic sales to be down 1% to flat in 2024 from 2023, compared with previous guidance of flat to up to 1.5% growth.

Shares of Dentsply Sirona ( XRAY ) were down 4% in recent Wednesday premarket activity.

Price: 25.70, Change: -1.08, Percent Change: -4.03

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RB Global Insider Sold Shares Worth $380,700, According to a Recent SEC Filing
RB Global Insider Sold Shares Worth $380,700, According to a Recent SEC Filing
May 28, 2024
12:16 PM EDT, 05/28/2024 (MT Newswires) -- James J Jeter, Chief Revenue Officer, on May 24, 2024, sold 5,000 shares in RB Global ( RBA ) for $380,700. Following the Form 4 filing with the SEC, Jeter has control over a total of 26,410 shares of the company, with 23,267 shares held directly and 3,143 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1046102/000095017024064969/xslF345X03/ownership.xml...
Volkswagen to develop entry-level electric vehicles for 20,000 euros
Volkswagen to develop entry-level electric vehicles for 20,000 euros
May 28, 2024
FRANKFURT, May 28 (Reuters) - Volkswagen will develop low-cost electric vehicles in a bid to better compete with fierce Chinese rivals, Europe's largest carmaker said on Tuesday, after talks with Renault to team up on the project collapsed earlier this month. The target is to produce electric vehicles for the European market priced at around 20,000 euros ($21,746), the company...
DraftKings to See Hit From Likely Increase of Illinois Sports Betting Tax, Oppenheimer Says
DraftKings to See Hit From Likely Increase of Illinois Sports Betting Tax, Oppenheimer Says
May 28, 2024
12:22 PM EDT, 05/28/2024 (MT Newswires) -- DraftKings ( DKNG ) will see a negative impact from the likely increase of the Illinois sports betting tax, Oppenheimer said Tuesday in note to clients. On Sunday night, the Illinois Senate has passed a budget that includes a tax hike on sports betting companies, according to media reports. The legislation would make...
Asahi Kasei Makes $1.1B Offer For Swedish Drugmaker Calliditas Therapeutics, Enhancing Pharma Growth Strategy
Asahi Kasei Makes $1.1B Offer For Swedish Drugmaker Calliditas Therapeutics, Enhancing Pharma Growth Strategy
May 28, 2024
Japanese chemical company Asahi Kasei Corporation made a $1.1 billion (SEK 11.164 billion) takeover bid for Swedish pharmaceutical company Calliditas Therapeutics ( CALT ) AB . The deal offers 208 Swedish krona in cash per share and a concurrent offer for American Depositary Shares, each representing two Shares in Calliditas, for 416 Swedish krona in cash per ADS. The Calliditas board unanimously recommended that shareholders accept the deal.  Asahi Kasei, especially...
Copyright 2023-2026 - www.financetom.com All Rights Reserved